SIOX Insider Trading Activity and SEC Form 4 Filings
SIOX insider trading summary
No open-market insider purchases or sales of Sio Gene Therapies Inc. (SIOX) have been reported on SEC Form 4 in the past 12 months.
Latest SIOX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 23, 2021 | Pavan Cheruvu | Chief Executive Officer | Buy | $248K (100,000 @ $2.48) |
| Nov 24, 2020 | Atul Pande | Director | Buy | $23K (10,000 @ $2.34) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.